Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1093 | 1027 | 1125 | 1156 | 1238 | 1579 |
Fund Return | 9.26% | 2.68% | 12.53% | 4.96% | 4.36% | 4.67% |
Place in category | 54 | 47 | 53 | 10 | 16 | 4 |
% in Category | 6 | 4 | 6 | 2 | 3 | 1 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS Bond S Convert Global EUR I A1 | 4.35B | 7.18 | -1.06 | 4.55 | ||
UBS Bond S Convert Global EUR I A2a | 4.35B | 7.27 | -0.96 | 4.61 | ||
UBS Bond S Convert Global EUR I A2d | 4.35B | 7.28 | -0.96 | 4.61 | ||
UBS Bond S Convert Global EUR I A3a | 4.35B | 7.37 | -0.86 | 4.70 | ||
UBS Bond S Convert Global EUR I A3e | 4.35B | 7.38 | -0.86 | 4.70 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Euro High Yield Class R EUR Cap | 3.22B | 7.10 | 3.22 | 4.06 | ||
Euro High Yield Class Z EUR Cap | 3.22B | 7.87 | 4.00 | 4.84 | ||
Euro High Yield Class C EUR Cap | 3.22B | 6.55 | 2.71 | 3.59 | ||
Euro High Yield Class C EUR Dis | 3.22B | 6.49 | 2.65 | 3.51 | ||
Candriam Bonds Euro High Yield Clas | 3.22B | 6.51 | 2.61 | 3.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Teva Pharmaceutical Finance Netherlands II B.V 7.375% | XS2592804434 | 1.32 | - | - | |
LHMC Finco 2 S.a r.l. 7.25% | XS2059777594 | 1.01 | - | - | |
UBS Europ Fin Debt Sust EUR U-X Acc | LU2520351177 | 0.98 | - | - | |
Altice Financing S.A. 3% | XS2102493389 | 0.93 | - | - | |
Barclays PLC 7.125% | XS1998799792 | 0.91 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Strong Buy | Buy |
Technical Indicators | Neutral | BUY | BUY |
Summary | Neutral | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review